Search research articles
Contact Us
Filters
Showing results (21-30 of 285) with videos related to
Page
of 29
Sort By:
American Journal of Ophthalmology
|
December 15, 1994
Association and chance occurrence of aniridia and retinoblastoma
K W To, S Mukai, A H Friedman
Pharmacogenomics
|
August 2, 2014
Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments
Kenneth K W To, Miao Hu, Brian Tomlinson
Expert Opinion on Drug Discovery
|
June 1, 2021
An overview of rational design of mRNA-based therapeutics and vaccines
Kenneth K W To, William C S Cho
Cancer Drug Resistance (Alhambra, Calif.)
|
September 30, 2022
Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance
Kenneth K W To, William C S Cho
Current Molecular Pharmacology
|
February 14, 2022
Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Kenneth K W To, William C S Cho
ISRN Oncology
|
July 11, 2012
Adverse Cell Culture Conditions Mimicking the Tumor Microenvironment Upregulate ABCG2 to Mediate Multidrug Resistance and a More Malignant Phenotype
Grace M Y Cheng, Kenneth K W To
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
July 1, 1990
Optic disc neovascularization in association with Vogt-Koyanagi-Harada syndrome
K W To, A J Nadel, R J Brockhurst
Molecular and Cellular Biology
|
September 7, 2006
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma
Kenneth K W To, Z Zhan, Susan E Bates
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
November 1, 1995
Rifabutin use in inflammatory bowel disease
K W To, W G Tsiaras, W R Thayer
Cancer Drug Resistance (Alhambra, Calif.)
|
October 15, 2024
Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy
Kenneth K W To, Hang Zhang, William C Cho
Page
of 29
Search research articles
Search
Showing results (21-30 of 285) with videos related to
Sort By:
Page
of 29
American Journal of Ophthalmology
|
December 15, 1994
Association and chance occurrence of aniridia and retinoblastoma
K W To, S Mukai, A H Friedman
Pharmacogenomics
|
August 2, 2014
Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments
Kenneth K W To, Miao Hu, Brian Tomlinson
Expert Opinion on Drug Discovery
|
June 1, 2021
An overview of rational design of mRNA-based therapeutics and vaccines
Kenneth K W To, William C S Cho
Cancer Drug Resistance (Alhambra, Calif.)
|
September 30, 2022
Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance
Kenneth K W To, William C S Cho
Current Molecular Pharmacology
|
February 14, 2022
Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Kenneth K W To, William C S Cho
ISRN Oncology
|
July 11, 2012
Adverse Cell Culture Conditions Mimicking the Tumor Microenvironment Upregulate ABCG2 to Mediate Multidrug Resistance and a More Malignant Phenotype
Grace M Y Cheng, Kenneth K W To
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
July 1, 1990
Optic disc neovascularization in association with Vogt-Koyanagi-Harada syndrome
K W To, A J Nadel, R J Brockhurst
Molecular and Cellular Biology
|
September 7, 2006
Aberrant promoter methylation of the ABCG2 gene in renal carcinoma
Kenneth K W To, Z Zhan, Susan E Bates
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
November 1, 1995
Rifabutin use in inflammatory bowel disease
K W To, W G Tsiaras, W R Thayer
Cancer Drug Resistance (Alhambra, Calif.)
|
October 15, 2024
Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy
Kenneth K W To, Hang Zhang, William C Cho
Page
of 29